Scientific Programme

0845 - 0900 Opening Ceremony
0900 - 0930 Keynote Lecture – Ventricular Assist Devices: Developments in Asia and Global Outlook for the Next 10 Years
Mandeep R Mehra
Session I:
HEART FAILURE PROGRAMME ADMINISTRATION AND ECONOMICS
Moderators: Sek-Ying Chair, Erik Fung
0930 - 0950 The Epidemiology and Economics of Heart Failure
Martin R Cowie
0950 - 1010 The Heart Transplant and VAD Programme at St Vincent’s Hospital, Sydney
Peter S Macdonald
1010 - 1030 On Setting Up a Heart Transplant Programme in Bangkok
Teerapat Yingchoncharoen
1030 - 1050 Updates on Cardiac Transplantation and LVAD Implants Across the UK and Europe
Steven SL Tsui
1050 - 1100 Q & A Session
1100 - 1120 Coffee Break
Concurrent Session II
HEART FAILURE MANAGEMENT IN THE OUTPATIENT SETTING
Moderators: Anna KY Chan, Victor YH Cheng, Cynthia Huie-Rose
Concurrent Session III
CARE PROGRAMMES FOR ADVANCED HF PATIENTS AND END-OF-LIFE SUPPORT
Moderators: Elsie Hui, Daniel KL Yuk
1120 - 1140 Office Management of Advanced Heart Failure
Martin R Cowie
Nurse-led Ambulatory Heart Failure Clinic at Queen Elizabeth Hospital, Hong Kong SAR
Cecilia MC Chan
1140 - 1200 Optimizing Heart Failure Care by Multi-disciplinary Heart Failure Clinic (MHFC)
Kevin KH Kam
Reversibility of Frailty in LVAD and Heart Transplant Patients
Peter S Macdonald
1200 - 1220 Challenging Cases from Queen Elizabeth Hospital, Hong Kong SAR
Sammy CS Chiang
Transitional States in Frailty: Implications for End-of-Life Support in Heart Failure
Jenny SW Lee
1220 - 1240 Using Mobile App to Empower Care and Self-management in Post-LVAD Patients
Jesus (Jessie) M Casida
When Is It Time to Switch the ICD Off in a Heart Failure Patient?
Li-Li Cheung
1240 - 1300 HF Management in Outpatient Setting in Macau
Gary IL Leong
Hospice and Palliative Care for Advanced Cardiac Diseases in Hong Kong
Raymond SK Lo
1300 - 1310 Q & A Session
1310 - 1400 Lunch
Concurrent Session IV
CARDIOGENIC SHOCK
Moderators: Charles D Gomersall, Bryan PY Yan
Concurrent Session V
SURGERY FOR HEART FAILURE
Moderators: Sylvia SW Au, Clement SW Chiu
1400 - 1420 Challenges in Shock Management in the Emergency Department
Colin A Graham
LV Reconstruction Surgery
Steven SL Tsui
1420 - 1440 The Shock Team Approach: The Rationale and Evidence
Michael S Kiernan
Surgery for Heart Failure: Experiences from Severance Cardiovascular Hospital, Seoul, Korea
Jung-Hwan Kim
1440 - 1500 A Life Support-based Comprehensive Treatment Regimen Dramatically Reduced In-hospital Mortality of Fulminant Myocarditis Patients
Dao-Wen Wang
Update of LVAD therapy in Japan
Goro Matsumiya
1500 - 1520 Impella Use in Protected PCI and Cardiogenic Shock
Ka-Lung Chui
VAD Surgery and Mechanical Circulatory Support at the National Heart Centre Singapore
Cumaraswamy Sivathasan
1520 - 1540 ECMO and MCS for Patients Undergoing PCI: Experience from Taipei Veterans General Hospital
Wei-Ting Wang
Surgical Care and Perioperative Nursing Management of LVADs
Jesus (Jessie) M Casida
1540 - 1550 Q & A Session
1550 - 1610 Coffee Break
Concurrent Session VI
COMPLICATIONS OF MECHANICAL CIRCULATORY SUPPORT AND TRANSPLANT
Moderators: Joseph YS Chan, Erik Fung
Concurrent Session VII
CARDIOMYOPATHIES, PULMONARY HYPERTENSION AND RIGHT HEART FAILURE
Moderators: Gary SH Cheung, Guangming Tan
1610 - 1630 Renal Complications in LVAD and Heart Transplant Patients
Michael S Kiernan
Should We Be Using Digoxin for Treating Heart Failure in 2018?
Ganesan Karthikeyan
1630 - 1650 Stroke Outcomes in LVAD Patients
Michael KL Wong
Management of Pulmonary Hypertension in SLE patients
Priscilla CH Wong
1650 - 1710 Managing Infections Associated with LVADs
Ka-Lee Kerk
Advances in Medical and Interventional Treatments for CTEPH
Yu Taniguchi
1710 - 1730 Malignancies in Heart Transplant Patients: Experience in Hong Kong
Katherine YY Fan
Fabry Disease in East Asia
Alex PW Lee
1730 - 1750 CardioMEMSTM in VAD patients
Erik Fung
Epidemiology of Heart Failure in South Asia
Ambuj Roy
1750 - 1810 Limb Ischaemia in Patients Undergoing ECMO
Kai-Man Chan
Hypertrophic Cardiomyopathy: Pathogenesis, Therapies and Disease Modulation
Polakit Teekakirikul
1810 - 1820 Q & A Session

* Please note that the Organising Committee reserves the right to change the programme without prior notice.